Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019) [Phase 2]
Phase 2 trial evaluating rituximab for schizophrenia spectrum disorders has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: The Effect of Illness Management Skill Training Applied to Patients With Schizophrenia [NA]
This clinical trial update reports on a study evaluating Illness Management Skill Training for patients with schizophrenia, with the trial s…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: The Effects of Mindfulness and Web-Based Physical Activity Program in Patients With Schizophrenia [NA]
The document provides an update on a completed clinical trial evaluating mindfulness and a web-based physical activity program in patients w…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in Japan [Phase 3]
A Phase 3 clinical trial evaluating the long-term safety and tolerability of SEP-363856 in Japanese patients with schizophrenia has been ter…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: 18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia [Phase 1]
Phase 1 PET study evaluating dopamine synthesis capacity in the whole striatum after 2 weeks of ralmitaront versus placebo in people with sc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis [Phase 4]
A Phase 4 clinical trial assessing gamma-aminobutyric acid (GABA) function in psychosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive Training [NA]
This completed Vanderbilt University trial compares virtual reality training for social skills in schizophrenia to cognitive training, with …
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Explorations of the Normal Neural Behavioral and Pathological Bases of Metacognition
A clinical trial exploring the neural and behavioral bases of metacognition in schizophrenia with impaired insight has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Metacognitive and Insight Therapy for Persons With Schizophrenia (RCT MERIT) [NA]
Completed randomized controlled trial MERIT evaluated metacognitive and insight therapy for schizophrenia spectrum disorders; results have b…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Neural Biomarkers of Clozapine Response
A completed clinical trial from the University of Pittsburgh examining neural biomarkers associated with clozapine response in schizophrenia…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Validation of a Clinical Screening Grid for Syndromic Schizophrenia [NA]
A ClinicalTrials.gov update shows termination of a trial validating a screening grid for syndromic schizophrenia.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: The Effectiveness and Efficacy of the Combination of the Integrated Psychological Therapy and Metacognitive Training. [Phase 2]
Phase 2 clinical trial evaluating the effectiveness and efficacy of combining Integrated Psychological Therapy with Metacognitive Training f…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001) [Phase 1]
Phase 1 study of MK-5720 in participants with schizophrenia completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Safety and Tolerability of Open-Labeled Iloperidone in Adolescents [Phase 4]
This Phase 4 open-label study evaluates the safety and tolerability of iloperidone in adolescents with schizophrenia or bipolar I disorder a…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Contingency Management for Problematic Behavior Reduction in the Community [NA]
A completed clinical trial evaluating contingency management to reduce problematic behaviors in community settings among individuals with sc…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Neurocognition After Perturbed Sleep [NA]
This is a completed clinical trial assessing neurocognition after perturbed sleep in individuals with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia [Phase 4]
Phase 4 clinical trial update evaluating high-dose lurasidone for treatment-resistant schizophrenia.
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: The Efficacy of Neural Stimulation in Individuals With Schizophrenia [NA]
This update reports the completed results of a neural stimulation intervention in individuals with schizophrenia. Results were posted on 202…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia [Phase 2]
Phase 2 clinical trial update examining a combination of NMDA-enhancing and antioxidant treatments for schizophrenia; recruitment is current…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Effects of Aerobic Exercise, Cognitive Remediation and Combined Intervention in Schizophrenia [NA]
This clinical trial update notes the completion of a study evaluating aerobic exercise, cognitive remediation, and a combined intervention i…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Implementation of a Tool for Reduction of Cardiovascular Risk in Patients with Severe Mental Disorders ( HEALTHYHEART )
A completed clinical trial evaluating the implementation of a tool to reduce cardiovascular risk in patients with schizophrenia and related …
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: A Register Study of Effects Following Local Variation in Rates of Involuntary Care
A register study assessing outcomes after local variation in involuntary care rates among people with schizophrenia and bipolar disorder; th…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Effect of Food and Age on the Pharmacokinetics of LY03017 [Phase 1]
This update describes a Phase 1 pharmacokinetic study of LY03017 evaluating the effects of food and age on its pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Minnesota Community-Based Cognitive Training in Early Psychosis [NA]
Update on the completed clinical trial of Minnesota's community-based cognitive training for people with early psychosis; results have been …
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: The Effects of Psyllium Seed on Body Weight and Metabolic Syndrome Indicators in Patients with Schizophrenia [NA]
A completed clinical trial evaluated the effects of psyllium seed on body weight and metabolic syndrome indicators in overweight or obese pa…